VitriVax

VitriVax is a biotechnology start-up that develops vaccine formulation platforms, dedicated to designing innovative solutions to maximize the global accessibility and utility of human and animal vaccines, which can save lives and protect our world from preventable diseases. VitriVax has designed its proprietary Atomic Layering Thermal-stable Antigen and Adjuvant (ALTA) technology platform to enable thermostable single-shot vaccines for a wide range of indications while maintaining or even potentially enhancing the immune response of the vaccines. ALTA can be applied to various vaccine antigens and adjuvants to prevent thermal and chemical degradation and achieve controlled release, combining an initial dose + additional booster doses in a single injection. These technologies can also facilitate the co-formulation of multiple otherwise incompatible antigens in a single injection.